William Geist - Aug 15, 2023 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Role: PRESIDENT, PROTEIN SCIENCES
Signature: /s/ Andrew Nick as Attorney-in-Fact for William Geist pursuant to Power of Attorney previously filed
Stock symbol: TECH
Transactions as of: Aug 15, 2023
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 12/14/2023, 06:15 PM
Date Of Original Report: Aug 17, 2023
Previous filing: Aug 17, 2022
Next filing: Nov 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TECH	Restricted Stock Units	Award	$0	+9.07K		$0.00	9.07K	Aug 15, 2023	Common Stock	9.07K		Direct	F1, F2
transaction	TECH	Stock Options (Right to Buy)	Award	$0	+24.4K		$0.00	24.4K	Aug 15, 2023	Common Stock	24.4K	$84.61	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2	Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Remarks:

This amendment is being filed to correct the number of restricted stock units and performance options being granted.